Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy

L. Garattini, F. Tediosi, E. Di Cintio, D. Yin, F. Parazzini

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

This study set out: (1) to describe resource utilization patterns among four groups of HIV-infected patients at different stages of the disease, and (2) to estimate the direct hospital costs of HIV/AIDS care among these patients in Italy. It is a multi-centre, prospective observational study conducted between August 1997 and July 1998. The 483 patients, enrolled in five infectious diseases departments located in different areas of Italy, were stratified into four groups according to their CD4 + lymphocyte cell count and status of AIDS Defining Illness (ADI) at enrolment. Average direct hospital costs (L=Italian Lire, 1997 exchange rate US$ 1 = 1,704 Italian Lire) were L. 23,725,584 (US$ 13,923.5), L. 15,208,287 (US$ 8,925.1), L. 11,942,761 (US$ 7,008.7) and L.7,660,942 (US$ 4,495.9) for the four groups of patients. More than 80% of patients in the first group and about 65% of patients in the second group received highly active antiretroviral therapy (HAART). The proportion of patients receiving HAART in the third and fourth group increased from 37.1% to 56.5% and from 15.3% to 31.5%. The number of hospital days observed in this study was much lower than previously published numbers in Italy. These results may indicate a shift of costs from hospitalisation to outpatient care and ARV.

Original languageEnglish
Pages (from-to)733-741
Number of pages9
JournalAIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
Volume13
Issue number6
DOIs
Publication statusPublished - 2001

Fingerprint

Hospital Costs
Highly Active Antiretroviral Therapy
Italy
Acquired Immunodeficiency Syndrome
AIDS
utilization
HIV
costs
resources
Group
CD4 Lymphocyte Count
outpatient care
Ambulatory Care
hospitalization
Observational Studies
contagious disease
Communicable Diseases
Patient Care
Hospitalization
illness

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)
  • Social Sciences (miscellaneous)

Cite this

Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy. / Garattini, L.; Tediosi, F.; Di Cintio, E.; Yin, D.; Parazzini, F.

In: AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 13, No. 6, 2001, p. 733-741.

Research output: Contribution to journalArticle

@article{e708a1f3a52f4b7c8aadd882ea90a87d,
title = "Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy",
abstract = "This study set out: (1) to describe resource utilization patterns among four groups of HIV-infected patients at different stages of the disease, and (2) to estimate the direct hospital costs of HIV/AIDS care among these patients in Italy. It is a multi-centre, prospective observational study conducted between August 1997 and July 1998. The 483 patients, enrolled in five infectious diseases departments located in different areas of Italy, were stratified into four groups according to their CD4 + lymphocyte cell count and status of AIDS Defining Illness (ADI) at enrolment. Average direct hospital costs (L=Italian Lire, 1997 exchange rate US$ 1 = 1,704 Italian Lire) were L. 23,725,584 (US$ 13,923.5), L. 15,208,287 (US$ 8,925.1), L. 11,942,761 (US$ 7,008.7) and L.7,660,942 (US$ 4,495.9) for the four groups of patients. More than 80{\%} of patients in the first group and about 65{\%} of patients in the second group received highly active antiretroviral therapy (HAART). The proportion of patients receiving HAART in the third and fourth group increased from 37.1{\%} to 56.5{\%} and from 15.3{\%} to 31.5{\%}. The number of hospital days observed in this study was much lower than previously published numbers in Italy. These results may indicate a shift of costs from hospitalisation to outpatient care and ARV.",
author = "L. Garattini and F. Tediosi and {Di Cintio}, E. and D. Yin and F. Parazzini",
year = "2001",
doi = "10.1080/09540120120076896",
language = "English",
volume = "13",
pages = "733--741",
journal = "AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV",
issn = "0954-0121",
publisher = "Routledge",
number = "6",

}

TY - JOUR

T1 - Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy

AU - Garattini, L.

AU - Tediosi, F.

AU - Di Cintio, E.

AU - Yin, D.

AU - Parazzini, F.

PY - 2001

Y1 - 2001

N2 - This study set out: (1) to describe resource utilization patterns among four groups of HIV-infected patients at different stages of the disease, and (2) to estimate the direct hospital costs of HIV/AIDS care among these patients in Italy. It is a multi-centre, prospective observational study conducted between August 1997 and July 1998. The 483 patients, enrolled in five infectious diseases departments located in different areas of Italy, were stratified into four groups according to their CD4 + lymphocyte cell count and status of AIDS Defining Illness (ADI) at enrolment. Average direct hospital costs (L=Italian Lire, 1997 exchange rate US$ 1 = 1,704 Italian Lire) were L. 23,725,584 (US$ 13,923.5), L. 15,208,287 (US$ 8,925.1), L. 11,942,761 (US$ 7,008.7) and L.7,660,942 (US$ 4,495.9) for the four groups of patients. More than 80% of patients in the first group and about 65% of patients in the second group received highly active antiretroviral therapy (HAART). The proportion of patients receiving HAART in the third and fourth group increased from 37.1% to 56.5% and from 15.3% to 31.5%. The number of hospital days observed in this study was much lower than previously published numbers in Italy. These results may indicate a shift of costs from hospitalisation to outpatient care and ARV.

AB - This study set out: (1) to describe resource utilization patterns among four groups of HIV-infected patients at different stages of the disease, and (2) to estimate the direct hospital costs of HIV/AIDS care among these patients in Italy. It is a multi-centre, prospective observational study conducted between August 1997 and July 1998. The 483 patients, enrolled in five infectious diseases departments located in different areas of Italy, were stratified into four groups according to their CD4 + lymphocyte cell count and status of AIDS Defining Illness (ADI) at enrolment. Average direct hospital costs (L=Italian Lire, 1997 exchange rate US$ 1 = 1,704 Italian Lire) were L. 23,725,584 (US$ 13,923.5), L. 15,208,287 (US$ 8,925.1), L. 11,942,761 (US$ 7,008.7) and L.7,660,942 (US$ 4,495.9) for the four groups of patients. More than 80% of patients in the first group and about 65% of patients in the second group received highly active antiretroviral therapy (HAART). The proportion of patients receiving HAART in the third and fourth group increased from 37.1% to 56.5% and from 15.3% to 31.5%. The number of hospital days observed in this study was much lower than previously published numbers in Italy. These results may indicate a shift of costs from hospitalisation to outpatient care and ARV.

UR - http://www.scopus.com/inward/record.url?scp=0035662880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035662880&partnerID=8YFLogxK

U2 - 10.1080/09540120120076896

DO - 10.1080/09540120120076896

M3 - Article

VL - 13

SP - 733

EP - 741

JO - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

JF - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

SN - 0954-0121

IS - 6

ER -